MELISSA KRUEGER: Open Payments
NPI 1023740487 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$523 in 20 payments from 13 companies in 2025. Trend: 2023 $2,379 · 2024 $1,078 · 2025 $523
Food & beverage: $428Education: $95
| Company | Payments | Amount |
|---|---|---|
| Genentech USA, Inc. | 6 | $114 |
| Astellas Pharma US Inc | 1 | $95 |
| Novartis Pharmaceuticals Corporation | 3 | $79 |
| Geron Corporation | 1 | $33 |
| Daiichi Sankyo Inc. | 1 | $27 |
| JAZZ PHARMACEUTICALS INC. | 1 | $27 |
| TerSera Therapeutics LLC | 1 | $25 |
| Janssen Biotech, Inc. | 1 | $25 |
| Gilead Sciences, Inc. | 1 | $25 |
| BeOne Medicines USA, Inc. | 1 | $24 |
Products named: Tecentriq, Rubraca, RYTELO, PLUVICTO, KISQALI, Enhertu, ZEPZELCA, Zoladex.
Industry payments across IL — which companies pay providers there.
